• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在微囊化胰岛移植中胰岛α细胞数量得以维持。

Islet alpha cell number is maintained in microencapsulated islet transplantation.

作者信息

Bohman Sara, King Aileen J F

机构信息

Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.

Beta Cell Development and Function Group, Division of Reproduction and Endocrinology, Hodgkin Building 2.4N, Guy's Campus, King's College, London SE1 1UL, UK.

出版信息

Biochem Biophys Res Commun. 2008 Dec 12;377(2):729-733. doi: 10.1016/j.bbrc.2008.10.059. Epub 2008 Oct 23.

DOI:10.1016/j.bbrc.2008.10.059
PMID:18950602
Abstract

Islet transplantation can reverse hyperglycaemia in Type 1 diabetes patients. One problem in islet transplantation is a loss of beta cell mass as well as blunted glucagon responses from the grafted islets. It has been suggested that alpha cell loss is associated with close contact of the alpha cells with the implantation organ. In the present study we made use of microencapsulation, where transplanted islets are not in direct contact with the host implantation site. After transplantation, the number of glucagon cells stained per microencapsulated islet section was increased whereas the number of insulin cells stained was decreased. DNA content of the islets was reduced, as was insulin content, whereas glucagon content was unchanged. This indicates that cell number in transplanted microencapsulated islets diminishes, which can be accounted for by loss of beta cells. However, in contrast to previous studies using non-encapsulated islets, alpha cell number seems to be maintained.

摘要

胰岛移植可逆转1型糖尿病患者的高血糖症。胰岛移植中的一个问题是β细胞数量减少以及移植胰岛的胰高血糖素反应减弱。有人提出,α细胞的丢失与α细胞与植入器官的密切接触有关。在本研究中,我们利用了微囊化技术,即移植的胰岛不与宿主植入部位直接接触。移植后,每个微囊化胰岛切片中染色的胰高血糖素细胞数量增加,而染色的胰岛素细胞数量减少。胰岛的DNA含量降低,胰岛素含量也降低,而胰高血糖素含量不变。这表明移植的微囊化胰岛中的细胞数量减少,这可以用β细胞的丢失来解释。然而,与之前使用未封装胰岛的研究不同,α细胞数量似乎得以维持。

相似文献

1
Islet alpha cell number is maintained in microencapsulated islet transplantation.在微囊化胰岛移植中胰岛α细胞数量得以维持。
Biochem Biophys Res Commun. 2008 Dec 12;377(2):729-733. doi: 10.1016/j.bbrc.2008.10.059. Epub 2008 Oct 23.
2
The effect of capsule composition in the reversal of hyperglycemia in diabetic mice transplanted with microencapsulated allogeneic islets.微囊化同种异体胰岛移植的糖尿病小鼠中胶囊成分对高血糖逆转的影响。
Diabetes Technol Ther. 2003;5(4):653-63. doi: 10.1089/152091503322250677.
3
Correction of hyperglycemia in type 1 diabetic models by transplantation of encapsulated insulin-producing cells derived from mouse embryo progenitor.通过移植源自鼠胚胎祖细胞的包被胰岛素分泌细胞纠正 1 型糖尿病模型的高血糖症。
J Endocrinol. 2011 Mar;208(3):245-55. doi: 10.1530/JOE-10-0378. Epub 2011 Jan 6.
4
Islet remodeling in female mice with spontaneous autoimmune and streptozotocin-induced diabetes.患有自发性自身免疫性和链脲佐菌素诱导性糖尿病的雌性小鼠的胰岛重塑
PLoS One. 2014 Aug 7;9(8):e102843. doi: 10.1371/journal.pone.0102843. eCollection 2014.
5
α-Cell loss from islet impairs its insulin secretion in vitro and in vivo.α 细胞从胰岛中丧失会损害其体内外的胰岛素分泌。
Islets. 2011 Mar-Apr;3(2):58-65. doi: 10.4161/isl.3.2.15036. Epub 2011 Mar 1.
6
Harnessing the Foreign Body Reaction in Marginal Mass Device-less Subcutaneous Islet Transplantation in Mice.利用小鼠边缘性无肿块无装置皮下胰岛移植中的异物反应
Transplantation. 2016 Jul;100(7):1474-9. doi: 10.1097/TP.0000000000001162.
7
Diabetes Is Reversed in a Murine Model by Marginal Mass Syngeneic Islet Transplantation Using a Subcutaneous Cell Pouch Device.使用皮下细胞袋装置进行边缘质量同基因胰岛移植可在小鼠模型中逆转糖尿病。
Transplantation. 2015 Nov;99(11):2294-300. doi: 10.1097/TP.0000000000000864.
8
XIAP inhibition of β-cell apoptosis reduces the number of islets required to restore euglycemia in a syngeneic islet transplantation model.XIAP 抑制β细胞凋亡减少了同种胰岛移植模型中恢复正常血糖所需的胰岛数量。
Islets. 2010 Jan-Feb;2(1):18-23. doi: 10.4161/isl.2.1.9997.
9
No differences in efficacy between noncultured and cultured islets in reducing hyperglycemia in a nonvascularized islet graft model.在非血管化胰岛移植模型中,非培养胰岛和培养胰岛在降低高血糖方面的疗效无差异。
Diabetes Technol Ther. 2006 Oct;8(5):536-45. doi: 10.1089/dia.2006.8.536.
10
Alginate-microencapsulation of human stem cell-derived β cells with CXCL12 prolongs their survival and function in immunocompetent mice without systemic immunosuppression.人干细胞来源的β细胞的海藻酸钙微囊化与 CXCL12 联合使用可延长其在免疫活性小鼠中的存活和功能,而无需全身免疫抑制。
Am J Transplant. 2019 Jul;19(7):1930-1940. doi: 10.1111/ajt.15308. Epub 2019 Mar 25.

引用本文的文献

1
Validation of Current Good Manufacturing Practice Compliant Human Pluripotent Stem Cell-Derived Hepatocytes for Cell-Based Therapy.现行良好生产规范 compliant 人多能干细胞衍生肝细胞用于细胞治疗的验证。
Stem Cells Transl Med. 2019 Feb;8(2):124-137. doi: 10.1002/sctm.18-0084. Epub 2018 Nov 19.
2
Imatinib prevents beta cell death in vitro but does not improve islet transplantation outcome.伊马替尼可在体外预防β细胞死亡,但不能改善胰岛移植结果。
Ups J Med Sci. 2016 May;121(2):140-5. doi: 10.3109/03009734.2016.1151090. Epub 2016 Mar 8.
3
Different susceptibility of rat pancreatic alpha and beta cells to hypoxia.
大鼠胰腺α和β细胞对缺氧的敏感性不同。
Histochem Cell Biol. 2012 Jun;137(6):801-10. doi: 10.1007/s00418-012-0925-4. Epub 2012 Feb 5.
4
Nano-scale encapsulation enhances allograft survival and function of islets transplanted in a mouse model of diabetes.纳米级封装技术增强了糖尿病小鼠模型中胰岛移植的同种异体移植物的存活和功能。
Diabetologia. 2012 Apr;55(4):1081-90. doi: 10.1007/s00125-011-2431-y. Epub 2012 Jan 14.
5
Microencapsulating and Banking Living Cells for Cell-Based Medicine.用于细胞治疗药物的活细胞微囊化与储存
J Healthc Eng. 2011 Dec;2(4):427-446. doi: 10.1260/2040-2295.2.4.427.
6
Increased recruitment but impaired function of leukocytes during inflammation in mouse models of type 1 and type 2 diabetes.1 型和 2 型糖尿病小鼠模型炎症期间白细胞募集增加但功能受损。
PLoS One. 2011;6(7):e22480. doi: 10.1371/journal.pone.0022480. Epub 2011 Jul 25.